Evelo Biosciences (EVLO) Financials

$0.00

$-0.04 (-99.75%)

As on 09-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	2.41	--	--	--	--	--
Gross Profit	-2.41	--	--	--	--	--
Operating Expenses	74.34	108.47	115.40	91.89	86.36	58.10
Operating Profit (EBIT)	-76.74	-108.47	-115.40	-91.89	-86.36	-58.10
Other Income	-1.30	--	-6.35	-1.37	1.08	1.16
Profit before Tax	-81.44	-113.60	-121.75	-93.26	-85.47	-56.95
Provision for Tax	0.91	0.93	0.43	0.41	0.19	-3.09
Profit after Tax (Net Income)	-82.35	-114.53	-122.18	-93.67	-85.66	-53.85
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-69.99	-114.53	-122.18	-93.67	-85.47	-60.88

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-26.71	-4.99	8.67	30.49	60.20	136.95
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.57	57.04	61.84	40.32	20.98	13.68
Current Liabilities	39.76	12.40	17.36	19.83	9.74	9.24
Total Liabilities	60.39	64.44	87.87	90.64	90.92	159.87

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	1.69	12.87	16.85	21.78	13.09	11.95
Current Assets	18.94	51.57	71.03	70.98	77.83	147.92
Total Assets	60.39	64.44	87.87	90.64	90.92	159.87
Total Debt*	33.95	51.14	56.29	40.04	19.63	12.31
Net Current Assets	-20.83	39.18	53.66	51.15	71.27	142.39

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-101.24	-96.73	-73.06	-71.98	-47.28
Cash Flow from Investing Activities	--	-0.62	-1.48	-1.32	51.97	-60.13
Cash from Financing Activities	--	81.66	97.54	65.47	4.99	162.01
Net Cash Inflow / Outflow	--	--	-0.67	-8.91	-15.02	54.61

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-83.78	-20.85	-45.66	-40.10	-53.38	-33.89
Cash EPS ($)	--	-20.48	-44.83	-39.24	-52.28	-32.68
Adjusted Book Value ($)	--	--	3.24	13.05	37.51	86.19
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-18.43	-36.15	-31.28	-44.85	-29.76
Free Cash Flow per Share ($)	--	-18.55	-36.72	-31.85	-46.74	-33.19

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-206.16	-180.36	-124.59	-74.79	-57.10
ROE (%)	--	-6,232.76	-624.11	-206.58	-86.90	-64.75
ROA (%)	-94.85	-150.38	-136.88	-103.18	-68.31	-52.89
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	6,354.09	--	1,923.43	6,831.95	-7,968.56	-4,654.62
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	34.07	7.83	-28.00	-6.40	-48.63	-117.63
Net Profit Growth (%)	29.80	6.26	-30.44	-9.34	-59.06	-92.01
EPS Growth (%)	-135.50	0.54	-0.14	0.25	-0.57	0.77
Book Value Growth (%)	-8,994.27	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.08	-0.13	-0.30	-0.08	-0.38
Price / Book Value	3.51	-1.77	1.87	0.93	0.11	0.15
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.39	-0.11	-0.04	0.01	0.61	3.02
Close Price ($)	3.92	32.20	121.40	241.80	81.20	260.20
High Price ($)	48.40	136.60	398.57	251.00	317.80	334.96
Low Price ($)	0.49	25.20	114.76	60.20	75.40	130.20
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-10.24	6.50	1.31	0.33	0.09
Short term debt to equity ratio	-1.27	-0.45	0.23	0.05	--	--
Current Ratio	0.48	4.16	4.09	3.58	7.99	16.02
Quick Ratio	0.48	--	--	--	--	--
Interest Coverage	-13.86	-23.20	-32.56	-43.57	-82.32	-37.17

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.